CHENODIOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chenodiol, and when can generic versions of Chenodiol launch?
Chenodiol is a drug marketed by Lgm Pharma and is included in one NDA.
The generic ingredient in CHENODIOL is chenodiol. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the chenodiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chenodiol
A generic version of CHENODIOL was approved as chenodiol by LGM PHARMA on October 22nd, 2009.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHENODIOL?
- What are the global sales for CHENODIOL?
- What is Average Wholesale Price for CHENODIOL?
Summary for CHENODIOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 80 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,000 |
| DailyMed Link: | CHENODIOL at DailyMed |
Recent Clinical Trials for CHENODIOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mayo Clinic | Phase 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| National Center for Research Resources (NCRR) | Phase 2 |
US Patents and Regulatory Information for CHENODIOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lgm Pharma | CHENODIOL | chenodiol | TABLET;ORAL | 091019-001 | Oct 22, 2009 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
